77.71
U S Physical Therapy Inc stock is traded at $77.71, with a volume of 115.76K.
It is down -0.21% in the last 24 hours and down -4.93% over the past month.
US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
See More
Previous Close:
$77.87
Open:
$78.2
24h Volume:
115.76K
Relative Volume:
0.55
Market Cap:
$1.16B
Revenue:
$795.49M
Net Income/Loss:
$62.33M
P/E Ratio:
156.45
EPS:
0.4967
Net Cash Flow:
$67.97M
1W Performance:
-1.18%
1M Performance:
-4.93%
6M Performance:
-2.85%
1Y Performance:
-4.09%
U S Physical Therapy Inc Stock (USPH) Company Profile
Name
U S Physical Therapy Inc
Sector
Industry
Phone
(713) 297-7000
Address
1300 WEST SAM HOUSTON PARKWAY SOUTH, HOUSTON, TX
Compare USPH vs HCA, THC, EHC, FMS, DVA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
USPH
U S Physical Therapy Inc
|
77.71 | 1.16B | 795.49M | 62.33M | 67.97M | 0.4967 |
|
HCA
Hca Healthcare Inc
|
421.21 | 91.33B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
263.46 | 21.67B | 21.46B | 2.65B | 3.35B | 19.23 |
|
EHC
Encompass Health Corp
|
121.04 | 11.99B | 6.07B | 793.80M | 464.40M | 5.9914 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.23 | 11.88B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
DVA
Davita Inc
|
181.33 | 11.68B | 13.84B | 1.10B | 1.49B | 10.42 |
U S Physical Therapy Inc Stock (USPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-26 | Resumed | Jefferies | Buy |
| Sep-18-25 | Resumed | JP Morgan | Overweight |
| Dec-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-16-24 | Initiated | JMP Securities | Mkt Outperform |
| Oct-07-24 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-22-23 | Initiated | JP Morgan | Overweight |
| Jun-30-23 | Initiated | BofA Securities | Buy |
| Dec-14-21 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Aug-06-21 | Reiterated | Barrington Research | Outperform |
| May-07-21 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-03-21 | Upgrade | Jefferies | Hold → Buy |
| Feb-26-21 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-08-20 | Reiterated | Barrington Research | Outperform |
| Apr-30-20 | Downgrade | Sidoti | Buy → Neutral |
| Mar-11-20 | Upgrade | Sidoti | Neutral → Buy |
| Feb-28-20 | Reiterated | Barrington Research | Outperform |
| Nov-08-19 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-08-19 | Initiated | William Blair | Outperform |
| Nov-03-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-08-17 | Upgrade | Sidoti | Neutral → Buy |
| Jul-03-17 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-17-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Nov-04-16 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Aug-05-16 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| May-06-16 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-01-16 | Downgrade | Jefferies | Buy → Hold |
| Nov-06-15 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| May-06-15 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Dec-12-13 | Reiterated | Dougherty & Company | Buy |
| Aug-23-13 | Reiterated | Dougherty & Company | Buy |
| Jan-14-13 | Reiterated | Dougherty & Company | Buy |
| Jul-09-10 | Initiated | JMP Securities | Mkt Outperform |
View All
U S Physical Therapy Inc Stock (USPH) Latest News
Avoiding Lag: Real-Time Signals in (USPH) Movement - Stock Traders Daily
US Physical Therapy (NASDAQ: USPH) CFO reports zero stock ownership - Stock Titan
USPH Stock Dips 1.13% as U.S. Physical Therapy Approaches Key SupportGrowth Factor - vinanet.vn
Youngsan University Produces 5th U.S. Physical Therapy Exam Passer - en.sedaily.com
USPH stock holds above $80 as investors weigh earnings and dividend profile - AD HOC NEWS
U.S. Physical Therapy Bets on Hospital Alliances to Drive Visits, Reimbursement - TradingView
U.S. Physical Therapy at 17th Annual Midwest IDEAS Conference: growth push - Investing.com Canada
USPH: Exclusive NYU Langone partnership and robust acquisitions drive growth and margin expansion - TradingView
US Physical Therapy (NYSE: USPH) COO retains 39,617 shares post tax move - Stock Titan
US Physical Therapy (USPH) lawyer surrenders stock for taxes - Stock Titan
U.S (USPH): Loses 1.06% to Close at $77.38 on the Day; Price Context: the Current Price Sits Inside the Supplied Technical RangeGEX Level - vinanet.vn
USPH | US Physical Therapy Inc FinancialsRevenue Breakdown - Quiver Quantitative
U.S (USPH) Range: Advances 0.86% to $78.21; Market Levels: $74.30 and $82.12 Define the Nearby Reference Levels in Latest TradingHigh Conviction Picks - vinanet.vn
U.S (USPH) Update: Moves 0.06% Higher to $77.62 in the Latest Reading; Levels: the Near-Term Reference Band Stretches From $73.74 to $81.50 in Latest TradingBreakaway Gap - vinanet.vn
Q2 2026 US Physical Therapy Inc Earnings Call Transcript - GuruFocus
U.S (USPH) Watch: Moves 1.28% Higher to $79.21 on the Day; Next Session: Support at $75.25 and Resistance at $83.17 Frame the Range in the Available RecordAdaptive Moving Average - vinanet.vn
Outpatient & Specialty Care Stocks Q2 Teardown: U.S. Physical Therapy (NYSE:USPH) Vs The Rest - Yahoo Finance
Rice Hall James & Associates LLC Purchases New Position in U.S. Physical Therapy, Inc. $USPH - MarketBeat
Citizens reiterates U.S. Physical Therapy stock rating on model adjustments By Investing.com - Investing.com Australia
U.S. Physical Therapy (USPH) Stock Looks Overvalued On Sales As 3 Year Returns Stay Weak - Sahm
Do USPH’s Softer Earnings and New CFO Appointment Reveal a Turning Point in Its Strategy? - simplywall.st
US Physical Therapy Appoints New Executive Vice President CFO - The Globe and Mail
U.S. Physical Therapy (NYSE:USPH) Trading Down 4.8%Here's Why - MarketBeat
U.S. Physical Therapy Announces New CFO - Baystreet.ca
USPH Looks 20.4% Undervalued on GF Value™ - GuruFocus
U.S. Physical Therapy, Inc. Announces CFO Changes - marketscreener.com
U.S. Physical Therapy Names Nchacha Etta Chief Financial Officer - citybiz
U.S. Physical Therapy names Nchacha Etta as CFO - Investing.com
U.S. Physical Therapy names Nchacha Etta as CFO By Investing.com - Investing.com Australia
U.S. Physical Therapy Announces CFO - Yahoo Finance
Bank of America Corp DE Grows Position in U.S. Physical Therapy, Inc. $USPH - MarketBeat
Kayne Anderson Rudnick (USPH) discloses 846,674-share, 5.6% stake in US Physical Therapy - Stock Titan
(USPH) and the Role of Price-Sensitive Allocations - Stock Traders Daily
U.S. Physical Therapy, Inc. (USPH) Stock Forecasts - finance.yahoo.com
U.S. Physical Therapy Updates Strategic Investor Presentation - TipRanks
Morgan Stanley (USPH) cuts U S Physical Therapy stake to 3.9% of shares - Stock Titan
U.S. Physical Therapy (USPH) Slips 1.8% to $80.13 as Support Levels Come into FocusLast Point Support - vinanet.vn
$78.92 | US Physical Therapy Inc (USPH) Stock Price Today - Binance
U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a Potential 16.22% Upside for Savvy Investors - DirectorsTalk Interviews
US Physical Therapy Reports Strong Q2 2026 Performance - TipRanks
USPH Maintains Outperform by Barrington Research -- Price Target Raised to $98.00 - GuruFocus
Barrington Research Issues Positive Forecast for U.S. Physical Therapy (NYSE:USPH) Stock Price - MarketBeat
US PHYSICAL THERAPY INC : BARRINGTON RESEARCH RAISES TARGET PRICE TO $98 FROM $90 - Bitget
BOOT BARN HOLDINGS INC : STEPHENS RAISES TARGET PRICE TO $207 FROM $196 - Bitget
CYTOKINETICS, INCORPORATED : LEERINK PARTNERS RAISES TARGET PRICE TO $103 FROM $100 - Bitget
SPECTRUM BRANDS HOLDINGS, INC. : MONNESS CRESPI HARDT RAISES TARGET PRICE TO $105 FROM $86 - Bitget
U.S. Physical Therapy, Inc. (NYSE:USPH) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Royal Bank of Canada Has $10.03 Million Stock Holdings in U.S. Physical Therapy, Inc. $USPH - MarketBeat
Barrington Maintains US Physical Therapy(USPH.US) With Buy Rating, Raises Target Price to $98 - Moomoo
Rising Sales but Falling EPS and New Dividend Might Change The Case For Investing In U.S. Physical Therapy (USPH) - simplywall.st
U.S. Physical Therapy Q2 Earnings Call Highlights - MarketBeat
U S Physical Therapy Inc Stock (USPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):